Net Net Stock Overview

Subscribe

To see hundreds more international net nets, consider subscribing

Overview

Rafael Holdings Inc
Real Estate
P/NCAV
0.55x
Ticker
RFL
Exchange
New York Stock Exchange
Country
United States
Close
1.74 $
Mkt Cap
40.5M $
EV
35.0M $
NCAV Burn Rate
19.3%
Current Ratio
23.01
Debt/Equity
0.02
EV/REV
125.6x
EV/EBIT
-2.3x
EV/FCF
-3.2x
Dilution
9.0% p.A
Total Net Income
-177.5M $
Cheapness
9.0%
Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. The Company-s segments include healthcare and real estate. The Company-s investments include Cornerstone Pharmaceuticals, Inc., which is a cancer metabolism-based therapeutics company; LipoMedix Pharmaceuticals Ltd., which is a clinical-stage pharmaceutical company; Barer Institute Inc., which is a preclinical cancer metabolism research operation; Cyclo Therapeutics Inc., which is a clinical-stage biotechnology company dedicated to developing medicines for patients and families living with diseases through its therapeutic asset like Trappsol and Cyclo; Day Three Labs, Inc., which offers pharmaceutical-grade technology like Unlokt, and Rafael Medical Devices, LLC, which is an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. Its real estate segment comprises of a portion of a commercial building in Israel.

Profitability

positive values --- Average negative values

Margins

--- Average

Valuation

positive values --- Average negative values

Dilution

--- Average